Abstract

Introduction: The Dent's Disease (Dd) Is An X-Linked Genetic Kidney Disease. We Undertook A Retrospective Study Of 4 Dd Observations Monitored In The Department Of Nephrology And Transplantation In Toulouse To Relate The History Of The Disease. Our Purpose Was To Show The Phenotypic Variability And Therapeutic Difficulties. Case Report Patient 1: Mr. G.O. - The Dd Was Discovered Incidentally Through Proteinuria Of 0.2 G/24 Hours Associated With Polyuria And Polydipsia Syndrome With Impaired Urine Concentrating And Diluting Capacity. A Minus 1 Standard Deviation Was Noted In One Year In Size And Weight, Which Lasted Up To 8 Years. At 7 Years Of Age, Hypercalciuria Of 8.4 Mg/Kg/Day With Nephrocalcinosis Appeared. From 16 Years Onward, Creatinine Degradation Gradually Reached A Peak Of 444 µmol/L Or A Glomerular Filtration Rate (Gfr), Under The Mdrd Formula, At 22 Ml /Minute In June 2014 In The Occurrence Of Epiglottitis. A Point Mutation Of The Chloride Channel Gene (Cncl5) Was Noted. Patient 2: Mr. B.R. The Dd Finding Was Incidental To Proteinuria Of 2.6 G/24 Hours Associated With Polydipsia-Polyuria During A School Visit At The Age Of 6 Without Change In Urinary Diluting Concentration. There Was An Episode Of Renal Colic When He Was 8 Years Old. When He Was 10, Hypercalciuria Of 9 Mg/Kg/Day Was Noticed, Nephrocalcinosis Too. From 14 Years Onward, Creatinine Gradually Deteriorated, Bringing Mr. B. R To Hemodialysis. Genetic Analysis Showed Adenine Deletion At Position 1751, Exon 10. Patient 3: Mr. G.C. The Discovery Of His Kidney Disease Was Fortuitous As Proteinuria Was Detected In Preventive Medicine When He Was 19 Years Old. There Was No Clinical Manifestation. His Gfr Altered To Average At 58 Ml / Min Using Mdrd Formula. Mutation Of Gene Cic.5 Was Noted. There Was Nephrocalcinosis Associated With Renal Cysts. Patient 4: Mr. T.C. Is The Younger Brother Of Mr. G.C. The Genetic Investigation Carried Out In The Family Showed That He Was Bearing The Same Mutation As His Elder Brother. He Had No Symptoms, At Most Proteinuria Of 0.5 G/G With Urinary Calcium/Creatinine Concentration Of 0.6. At The Age 20, His Kidneys Worked Normally. Conclusion: The Therapeutic Resources Were Limited. Several Questions Remained Unanswered, Namely The Impact Of Ace Inhibitors And Arbs In Slowing The Ckd; Also 25-35% Of Cases Of Dd Without Genetic Mutation Was Observed.

Highlights

  • Introduction TheDent's Disease (Dd) Is An X-Linked Genetic Kidney Disease

  • The Dent's disease (DD) comprises three familial syndromes characterized by hypercalciuric nephrolithiasis and X-linked transmission: X-linked recessive nephrolithiasis, hypophosphatemic rickets, connected to familial idiopathic low-molecular-weight proteinuria observed in Japanese patients

  • At the age of 7 years, hypercalciuria at 185 mg/24 h or 8.4/kg/day appeared for the first time, with urinary calcium/ creatinine ratio rising from 1.12 to 5.2 under fasting conditions while nephrocalcinosis lesions were noted

Read more

Summary

Introduction

The Dent's disease (DD) is an X-linked genetic kidney disease related to a major impairment in the proximal convoluted tubule (PCT). At the age of 7 years, hypercalciuria at 185 mg/24 h or 8.4/kg/day appeared for the first time, with urinary calcium/ creatinine ratio rising from 1.12 to 5.2 under fasting conditions while nephrocalcinosis lesions were noted. From 7-11 years old, he was given thiazide diuretics This therapy was stopped at 11 for treatment failure marked by persistent urinary calcium despite optimal dose. Proteinuria was exclusively tubular, 1.25 ± 0.88 g/l on average (Table 1) When he was 10, hypercalciuria at 290 mg/24 h, or 9 mg/kg/day was noted for the first time, with urinary calcium/ creatinine ratio which rose from 0.77 to 1; nephrocalcinosis lesions were apparent at the same time. The family genetic investigation showed that he was carrying the same mutation as his elder brother He had no symptoms, at most proteinuria of 0.5 g/g with urinary calcium/creatinine level of 0.6.

Discussion
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.